Thromboangiitis Obliterans: Clinical Trials

1 trial for Thromboangiitis Obliterans, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Thromboangiitis Obliterans: new trials by email Literature Review of Thromboangiitis Obliterans trials Research Report on Thromboangiitis Obliterans

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells - Critical Limb Ischemia, Buerger's Disease
Phase 4RecruitingCell Biopeutics Resources Sdn Bhd32024-01-012025-09-09

Narrower conditions

Chronic Limb-Threatening Ischemia (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Ischemia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peripheral Arterial Disease (1)  ·  Peripheral Vascular Diseases (1)  ·  Vascular Diseases (1)  ·  Vasculitis (1)

Sponsors

Cell Biopeutics Resources Sdn Bhd (1)

Countries

Malaysia (1)

Top investigators

Hanafiah Harunarashid, MS (1)